営業利益率
2012年以降
計算
AbbVie Inc.、営業利益率、長期的な傾向計算
| 営業利益率 | = | 100 | × | 営業利益1 | ÷ | 純収益1 | |
|---|---|---|---|---|---|---|---|
| 2023/12/31 | 23.49% | = | 100 | × | 12,757) | ÷ | 54,318) |
| 2022/12/31 | 31.21% | = | 100 | × | 18,117) | ÷ | 58,054) |
| 2021/12/31 | 31.89% | = | 100 | × | 17,924) | ÷ | 56,197) |
| 2020/12/31 | 24.81% | = | 100 | × | 11,363) | ÷ | 45,804) |
| 2019/12/31 | 39.03% | = | 100 | × | 12,983) | ÷ | 33,266) |
| 2018/12/31 | 19.49% | = | 100 | × | 6,383) | ÷ | 32,753) |
| 2017/12/31 | 33.99% | = | 100 | × | 9,592) | ÷ | 28,216) |
| 2016/12/31 | 36.60% | = | 100 | × | 9,384) | ÷ | 25,638) |
| 2015/12/31 | 32.97% | = | 100 | × | 7,537) | ÷ | 22,859) |
| 2014/12/31 | 17.09% | = | 100 | × | 3,411) | ÷ | 19,960) |
| 2013/12/31 | 30.14% | = | 100 | × | 5,664) | ÷ | 18,790) |
| 2012/12/31 | 31.65% | = | 100 | × | 5,817) | ÷ | 18,380) |
レポートに基づく: 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31).
1 百万米ドル
競合他社との比較
AbbVie Inc.、営業利益率、長期的な傾向、競合他社との比較
| AbbVie Inc. | Amgen Inc. | Gilead Sciences Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|
| 2023/12/31 | 23.49% | 29.35% | 28.24% | 30.85% | 16.00% |
| 2022/12/31 | 31.21% | 38.57% | 27.17% | 38.93% | 18.69% |
| 2021/12/31 | 31.89% | 31.44% | 36.72% | 55.67% | 25.57% |
| 2020/12/31 | 24.81% | 37.70% | 16.72% | 42.09% | 24.19% |
| 2019/12/31 | 39.03% | 43.57% | 19.38% | 28.10% | 17.99% |
| 2018/12/31 | 19.49% | 45.55% | 37.83% | 37.77% | 15.53% |
| 2017/12/31 | 33.99% | 45.76% | 55.04% | 35.41% | 14.19% |
| 2016/12/31 | 36.60% | 44.74% | 58.87% | 27.38% | 13.40% |
| 2015/12/31 | 32.97% | 40.44% | 69.03% | 30.51% | 13.77% |
| 2014/12/31 | 17.09% | 32.03% | 62.37% | 29.74% | 14.82% |
| 2013/12/31 | 30.14% | 32.25% | 41.87% | 36.11% | 12.30% |
| 2012/12/31 | 31.65% | 33.52% | 42.67% | 33.20% | 11.85% |
レポートに基づく: 10-K (報告日: 2023-12-31), 10-K (報告日: 2022-12-31), 10-K (報告日: 2021-12-31), 10-K (報告日: 2020-12-31), 10-K (報告日: 2019-12-31), 10-K (報告日: 2018-12-31), 10-K (報告日: 2017-12-31), 10-K (報告日: 2016-12-31), 10-K (報告日: 2015-12-31), 10-K (報告日: 2014-12-31), 10-K (報告日: 2013-12-31), 10-K (報告日: 2012-12-31).